Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Therapies × Immune Checkpoint Inhibitors × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 41 Carcinoma, Hepatocellular 27 Neoplasms 13 Melanoma 13 Stomach Neoplasms 12 Neoplasm Metastasis 12 Colorectal Neoplasms 11 Esophageal Neoplasms 10 Triple Negative Breast Neoplasms 9 Head and Neck Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Recurrence 7 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Carcinoma, Renal Cell 7 Biliary Tract Neoplasms 7 Esophageal Squamous Cell Carcinoma 6 Small Cell Lung Carcinoma 5 Rectal Neoplasms 5 Pancreatic Neoplasms 5 Colonic Neoplasms 5 Breast Neoplasms 5 Liver Neoplasms 4 Cholangiocarcinoma 4 Advanced NSCLC 4 Urinary Bladder Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Hyperthermia 3

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07230639 2025-12-26

MODIFI-CC

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Recruiting

Neoadjuvant Therapies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡